(EXD) |
| 0 (0%) 04-14 10:49 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Wed, 08 Apr 2026
Trinity Delta - Avacta: AVA6103 (FAP-Exd) starts Phase Ia FOCUS clinical trial - Vox Markets
Tue, 31 Mar 2026
Avacta announces first patient treated in Phase 1 FOCUS-01 - GlobeNewswire
Tue, 31 Mar 2026
Avacta Begins Phase 1 Trial of FAP-Exd Cancer Drug Candidate - National Today
Fri, 13 Feb 2026
BorgWarner Secures First 48V Electric Cross Differential Program - The EV Report
Thu, 12 Feb 2026
BorgWarner secures first 48V eXD programme in China - Automotive World
Wed, 11 Feb 2026
Inside BorgWarner’s new 48V tech that helps EVs grip icy roads - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |